Nationwide: the CMS-FDA RAPID device pathway, and why it likely won't touch your med spa

Key facts:

• On April 23, 2026, CMS and the FDA announced the RAPID coverage pathway.
• It aligns FDA authorization timing with Medicare coverage review for certain Breakthrough Devices.
• It applies only to eligible Class II and Class III devices for serious or life-threatening conditions.
• Elective cosmetic and aesthetic devices are not in scope.

What is RAPID?

On April 23, 2026, CMS and the FDA announced the RAPID (Regulatory Alignment for Predictable and Immediate Device) pathway. It coordinates the timing of FDA market authorization with Medicare's National Coverage Determination review, so eligible devices reach Medicare coverage faster. See the CMS announcement and the FDA announcement.

Does it apply to aesthetic devices?

Almost certainly not. RAPID applies only to certain FDA-designated Breakthrough Devices, which are for life-threatening or irreversibly debilitating conditions. The agencies did not identify elective cosmetic devices or routine med spa procedures as eligible. Energy-based systems, body contouring, and lasers stay under their existing FDA authorization pathways, such as 510(k), and state oversight.

What it means for your med spa

This one is mostly a good-to-know, not an action item. Still, it's a useful prompt to review how each of your device-based technologies is FDA-classified and authorized, and to make sure your marketing reflects the actual cleared indications. More detail is coming through a Federal Register notice and public comment.

FAQs

Will RAPID speed up coverage for my laser or body-contouring device?

No. Those are elective aesthetic devices and fall outside the Breakthrough Devices Program and RAPID.

What devices does RAPID cover?

Certain FDA-designated Breakthrough Devices for serious or life-threatening conditions.

Fresh Clinics helps med spa owners keep device marketing aligned with FDA-cleared indications. Learn more about Fresh Clinics membership.